June 18, 2024
North Africa Non-Invasive Prenatal Testing Market

Emerging Non-Invasive Prenatal Testing Market Is Propelled By Increasing Maternal Age By 6.9%

Non-invasive prenatal testing (NIPT) uses a blood sample from the mother to screen for genetic abnormalities in the fetus without any risks to the pregnancy. It has revolutionized prenatal care by offering a safer alternative to procedures like amniocentesis which carry risks of pregnancy loss. The test can detect the most common trisomies- trisomy 13, 18, and 21 in the early stages of pregnancy with high accuracy.

The Global North Africa Non-Invasive Prenatal Testing Market is estimated to be valued at USD 7.3 bn 2024 and is expected to exhibit a CAGR of 13.5%over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the North Africa Non-Invasive Prenatal Testing are Enraf-Nonius B.V., DJO Global, EMS Physio Ltd., Dynatronics Corporation, A. Algeo Limited, BTL Industries, Inc., HMS Medical Systems, Whitehall Manufacturing, Patterson Companies, Inc., and Isokinetics, Inc.

The growing demand for prenatal screening coupled with increasing risk awareness among expectant mothers is fueling the market growth. Moreover, the average maternal age in North Africa has risen in recent years, increasing the odds of chromosomal abnormalities.

Globally, North Africa represents one of the fastest expanding markets for NIPT. Major players are investing aggressively in the region by launching new service centers and expanding distribution networks to tap the potential offered by the large patient pool and rising healthcare spending.

Market Key Trends

The high priority for prenatal screening of genetic abnormalities is one of the major trends observed in the North Africa non-invasive prenatal testing market. The demand for early detection of Down syndrome, Edward syndrome, and Patau syndrome through advanced screening techniques like NIPT is growing significantly. Moreover, the increasing preference of expectant mothers and families for elective termination of pregnancies with genetic defects is steering the adoption of prenatal testing options. This has created growth opportunities for players to introduce innovative products and services in the market.

Porter’s Analysis

Threat of new entrants: It is moderate as it requires advance technology and large investments to enter this market.

Bargaining power of buyers: Buyers has high bargaining power due low switching costs.

Bargaining power of suppliers: Suppliers has low bargaining power due to presence of multiple diagnostic companies that can supply the required materials.

Threat of new substitutes: There is low threat of substitution as the technology is new and has benefit over other diagnostic methods.

Competitive rivalry: The competitive rivalry is high due to presence of multiple players offering similar products in this market.

Geographical Regions

North Africa Non-Invasive Prenatal Testing Market Demand  share in terms of value due to increasing availability and awareness of advanced healthcare facilities. Egypt holds the largest market share with presence of developed healthcare infrastructure and increasing adoption of advanced diagnostics.

Middle East region is expected to witness fastest growth during the forecast period owing to rising healthcare expenditures, rapid digitization of hospitals and growing demand for accurate prenatal screening to detect chromosomal abnormalities at early stages. The growth is further supported by expanding network of multi-specialty hospitals and clinics in GCC countries.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it